MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ANRO — Alto Neuroscience Inc.
NYSEAlto Neuroscience Inc.
$24.80
-0.51(-2.02%)
- O
- 25.64
- H
- 26.10
- L
- 23.87
- V
- 660.68K
⏱️ End-of-day dataAs of Oct 2, 2026
ANRO — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $26.38M | $17.65M | $13.78M | $14.76M | $16.08M | $16.82M |
| Prepaid Assets | $5.36M | $1.23M | $1.63M | $1.32M | $2.75M | $1.08M |
| Total Current Assets | $26.91M | $17.77M | $13.94M | $14.98M | $16.35M | $16.93M |
| Properties | $6.73M | $6.39M | $6.58M | $6.92M | $7.11M | $7.34M |
| Machinery Furniture Equipment | $1.03M | $1.03M | $1.03M | $1.12M | $1.12M | $1.12M |
| Leases | 246,000.00 | 246,000.00 | 246,000.00 | 246,000.00 | 246,000.00 | 246,000.00 |
| Accumulated Depreciation | $-1.71M | $-1.53M | $-1.37M | $-1.32M | $-1.16M | $-1.00M |
| Other Non Current Assets | 838,000.00 | 838,000.00 | $1.07M | $1.07M | $1.07M | 504,000.00 |
| Total Non Current Assets | $7.13M | $6.97M | $7.56M | $8.03M | $8.39M | $8.21M |
| Total Assets | $27.63M | $18.47M | $14.70M | $15.79M | $17.19M | $17.75M |
| Accounts Payable | $3.37M | $1.88M | $2.06M | $1.67M | $1.38M | $1.58M |
| Accrued Expenses | $6.31M | $7.71M | $5.87M | $5.49M | $5.00M | $7.56M |
| Short Term Debt | $3.44M | $1.74M | $1.12M | 973,000.00 | 876,000.00 | 870,000.00 |
| Total Current Liabilities | $13.12M | $11.32M | $9.04M | $8.13M | $7.26M | $10.01M |
| Long Term Debt | $19.77M | $22.22M | $26.40M | $26.34M | $25.56M | $16.07M |
| Total Non Current Liabilities | $19.77M | $22.22M | $26.40M | $26.34M | $25.56M | $16.07M |
| Total Liabilities | $32.89M | $33.55M | $35.45M | $34.47M | $32.82M | $26.08M |
| Common Stock | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 | 3,000.00 |
| Retained Earnings | $-22.79M | $-20.16M | $-18.55M | $-17.13M | $-15.36M | $-13.84M |
| Other Shareholders Equity | 13,000.00 | 22,000.00 | 14,000.00 | 31,000.00 | 14,000.00 | -101,000.00 |
| Total Shareholders Equity | $24.34M | $15.11M | $11.16M | $12.34M | $13.91M | $15.15M |
| Additional Paid In Capital | $47.12M | $35.28M | $29.70M | $29.46M | $29.26M | $29.00M |
| Other Current Assets | N/A | N/A | N/A | 936,000.00 | 23,000.00 | 30,000.00 |
| Derivative Product Liabilities | N/A | N/A | N/A | N/A | N/A | 0.00 |